Recent Developments in Transvaginal Mesh Litigation
Read a broader update on major litigation developments, FDA action, and how the overall transvaginal mesh landscape changed over time.
Read the litigation update →Transvaginal Mesh Lawsuits
Last updated: April 30, 2026
Transvaginal mesh lawsuits have involved allegations that certain pelvic mesh products caused serious complications, including erosion, chronic pain, infection, urinary problems, sexual dysfunction, and the need for revision surgery. This page is a starting point for readers who want to understand the broader litigation history, the status of the main federal pelvic mesh proceedings, and how public product-identification records may help connect a procedure to a manufacturer or product family.
Important:
This page provides general educational information and does not constitute legal advice.
Key Takeaways:
- Transvaginal mesh litigation focused on serious pelvic mesh complications and product warning allegations.
- The major federal pelvic mesh MDLs in the Southern District of West Virginia are no longer active in the way they once were.
- FDA action in 2019 stopped U.S. sales of surgical mesh intended for transvaginal repair of pelvic organ prolapse.
- Product identification still matters because readers often begin with operative reports, implant stickers, or revision records.
Start here:
What Is Transvaginal Mesh?
Transvaginal mesh refers to certain surgical mesh products used in procedures involving pelvic organ prolapse or stress urinary incontinence. Over time, many patients reported complications that led to major safety concerns, regulatory scrutiny, and large-scale product liability litigation.
Why Did Transvaginal Mesh Lawsuits Grow So Large?
These lawsuits grew in part because many claims involved similar allegations against major manufacturers, including claims involving product design, warnings, complications after implantation, and repeat surgeries. Large numbers of federal cases were centralized in pelvic mesh multidistrict litigations, often called MDLs.
What Is the Current Status of the Main Federal Mesh MDLs?
The largest pelvic mesh MDLs were centralized in the Southern District of West Virginia. The court’s MDL listings show the major proceedings involving Bard, American Medical Systems, Boston Scientific, Ethicon, and Coloplast as closed. That does not mean every legal question involving pelvic mesh disappeared, but it does mean the main federal MDL phase is no longer active in the same way it once was.
What Did the FDA Do?
FDA materials explain that in 2019 the agency ordered manufacturers to stop selling surgical mesh intended for transvaginal repair of pelvic organ prolapse in the United States. FDA guidance also explains that women who already received these products should continue routine follow-up care and speak with their healthcare providers about symptoms or complications.
What Kinds of Problems Were Alleged?
Lawsuits and public safety discussions often focused on allegations involving mesh erosion, chronic pelvic pain, infection, bleeding, urinary problems, painful intercourse, organ perforation, and the need for revision or removal surgery. In many cases, the disputes centered on whether the products were adequately tested, how risks were described, and whether warnings were sufficient.
Why Product Identification Matters
In many mesh cases, one of the most important questions is which product was actually implanted. Public FDA records may help identify a manufacturer, product family, or related clearance history. But exact identification often depends on medical records such as operative reports, implant stickers, hospital records, and revision surgery documentation.
Start Here: Key Transvaginal Mesh Resources
Transvaginal Mesh Manufacturers and Public Product Identifiers
Use the reference page to review manufacturers, product families, and selected public FDA identifiers that may help with product research.
Explore product identifiers →Why This Topic Still Matters
Even though the major federal MDLs are closed, readers still research this subject for several reasons. Some are trying to understand older litigation history. Others are reviewing medical records, identifying an implanted product, comparing manufacturers, or learning how pelvic mesh litigation fit into broader mass tort and product liability practice.
Frequently Asked Questions About Transvaginal Mesh Lawsuits
Are transvaginal mesh lawsuits still active?
The largest federal pelvic mesh MDLs are no longer active in the same way they once were. However, people still research transvaginal mesh because older procedures, complications, revision surgeries, product identification, and individual legal questions may still matter.
What did the FDA do about transvaginal mesh?
In 2019, the FDA ordered manufacturers to stop selling surgical mesh intended for transvaginal repair of pelvic organ prolapse in the United States. FDA materials also explain that women who already received these products should continue routine follow-up care and speak with healthcare providers about symptoms or complications.
What complications were alleged in transvaginal mesh lawsuits?
Reported allegations often involved mesh erosion, chronic pelvic pain, infection, bleeding, urinary problems, painful intercourse, organ perforation, and the need for revision or removal surgery.
What happened to the major federal pelvic mesh MDLs?
The major federal pelvic mesh multidistrict litigations were centralized in the Southern District of West Virginia. The major proceedings involving Bard, American Medical Systems, Boston Scientific, Ethicon, and Coloplast are now closed.
Why does product identification matter in transvaginal mesh cases?
Product identification matters because the manufacturer, product family, procedure type, and implant records may affect how someone researches the litigation history and possible claim issues. Operative reports, implant stickers, hospital records, and revision surgery records may help identify the device.
Where can someone find more information about mesh manufacturers and product names?
Readers can review public FDA materials and the Lawsuit Informer page on Transvaginal Mesh Manufacturers and Public Product Identifiers. Exact identification usually depends on medical records, operative reports, implant stickers, and hospital documentation.
Researching Other Active Lawsuits?
The major transvaginal mesh MDLs are largely closed, and most pelvic mesh claims face significant statute of limitations issues. If you're researching this topic for historical reference, the resources above are the best starting point.
If you're researching another active lawsuit category — including consumer products, medications, toxic exposure, or PFAS contamination — you can request a free, no-obligation case review on Lawsuit Center.
Educational purposes only. Not legal advice. No attorney-client relationship is formed.
Related Legal Guides
Recent Developments in Transvaginal Mesh Litigation
Read a broader update on major litigation developments, FDA action, and the overall status of mesh cases.
Transvaginal Mesh Manufacturers and Public Product Identifiers
Review manufacturers, product families, and public product-identification resources.
How Lawsuits Work
Get a simple overview of how legal claims are investigated, filed, and resolved over time.
Mass Torts
Understand how coordinated proceedings work when many similar claims move through court together.
Class Actions
Compare class actions with other forms of coordinated civil litigation.
